Clinical Trials Browser

Phase 2 × Gliosarcoma × Sirolimus × Clear all

NCT00672243 2013-08-07

Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma Multiforme

Phase 2 Completed

32 enrolled 13 charts

Brain Neoplasms, Glioblastoma, Gliosarcoma